Vitamin D and Diabetes

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2005 Jun 23

PMID 15971062

Citations 178

Authors

C Mathieu

C Gysemans

A Giulietti

R Bouillon

Affiliations

Soon will be listed here.

Abstract

Vitamin D deficiency predisposes individuals to type 1 and type 2 diabetes, and receptors for its activated form-1alpha,25-dihydroxyvitamin D3-have been identified in both beta cells and immune cells. Vitamin D deficiency has been shown to impair insulin synthesis and secretion in humans and in animal models of diabetes, suggesting a role in the development of type 2 diabetes. Furthermore, epidemiological studies suggest a link between vitamin D deficiency in early life and the later onset of type 1 diabetes. In some populations, type 1 diabetes is associated with certain polymorphisms within the vitamin D receptor gene. In studies in nonobese diabetic mice, pharmacological doses of 1alpha,25-dihydroxyvitamin D3, or its structural analogues, have been shown to delay the onset of diabetes, mainly through immune modulation. Vitamin D deficiency may, therefore, be involved in the pathogenesis of both forms of diabetes, and a better understanding of the mechanisms involved could lead to the development of preventive strategies.

Citing Articles

Nutritional intake of micronutrient and macronutrient and type 2 diabetes: machine learning schemes.

Rashidmayvan M, Mansoori A, Derakhshan-Nezhad E, Tanbakuchi D, Sangin F, Mohammadi-Bajgiran M J Health Popul Nutr. 2025; 44(1):31.

PMID: 39920736 PMC: 11806732. DOI: 10.1186/s41043-024-00712-2.

Redosing with Intralymphatic GAD-Alum in the Treatment of Type 1 Diabetes: The DIAGNODE-B Pilot Trial.

Casas R, Tompa A, Akesson K, Teixeira P, Lindqvist A, Ludvigsson J Int J Mol Sci. 2025; 26(1.

PMID: 39796229 PMC: 11720063. DOI: 10.3390/ijms26010374.

Eldecalcitol ameliorates diabetic osteoporosis and glucolipid metabolic disorder by promoting Treg cell differentiation through SOCE.

Jiang Y, Gao R, Ying Q, Li X, Dai Y, Song A Cell Mol Life Sci. 2024; 81(1):423.

PMID: 39367914 PMC: 11456014. DOI: 10.1007/s00018-024-05453-3.

Vitamin D efficacy in type 1 and type 2 diabetes.

Kawahara T, Okada Y, Tanaka Y J Bone Miner Metab. 2024; 42(4):438-446.

PMID: 38664254 DOI: 10.1007/s00774-024-01509-3.

Differences in Plasma 25-Hydroxyvitamin D Levels at Diagnosis of Celiac Disease and Type 1 Diabetes.

Marino M, Galeazzi T, Gesuita R, Ricci S, Catassi C, Cherubini V Nutrients. 2024; 16(5).

PMID: 38474871 PMC: 10934773. DOI: 10.3390/nu16050743.

References

Lee S, Clark S, Gill R, Christakos S . 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinology. 1994; 134(4):1602-10. DOI: 10.1210/endo.134.4.8137721. View

Verstuyf A, Verlinden L, Van Baelen H, Sabbe K, DHallewyn C, De Clercq P . The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings. J Bone Miner Res. 1998; 13(4):549-58. DOI: 10.1359/jbmr.1998.13.4.549. View

Adorini L, Penna G, Giarratana N, Roncari A, Amuchastegui S, Daniel K . Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J Steroid Biochem Mol Biol. 2004; 89-90(1-5):437-41. DOI: 10.1016/j.jsbmb.2004.03.013. View

Adams J, Sharma O, Gacad M, Singer F . Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest. 1983; 72(5):1856-60. PMC: 370476. DOI: 10.1172/JCI111147. View

Isaia G, Giorgino R, Adami S . High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care. 2001; 24(8):1496. DOI: 10.2337/diacare.24.8.1496. View

Takeuchi A, Reddy G, Kobayashi T, Okano T, Park J, Sharma S . Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects. J Immunol. 1998; 160(1):209-18. View

Taylor A, Wise P . Vitamin D replacement in Asians with diabetes may increase insulin resistance. Postgrad Med J. 1998; 74(872):365-6. PMC: 2360945. DOI: 10.1136/pgmj.74.872.365. View

Tanaka Y, Castillo L, DeLuca H . The 24-hydroxylation of 1,25-dihydroxyvitamin D3. J Biol Chem. 1977; 252(4):1421-4. View

Taniyama M, Yanagawa T, Yamada S, Maruyama T, Kasuga A, Ban Y . Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type 1 diabetes mellitus in the Japanese population. BMC Med Genet. 2001; 2:7. PMC: 34514. DOI: 10.1186/1471-2350-2-7. View

10.

Hewison M, Freeman L, Hughes S, Evans K, Bland R, Eliopoulos A . Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol. 2003; 170(11):5382-90. DOI: 10.4049/jimmunol.170.11.5382. View

11.

Cade C, Norman A . Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology. 1986; 119(1):84-90. DOI: 10.1210/endo-119-1-84. View

12.

van Halteren A, Tysma O, van Etten E, Mathieu C, Roep B . 1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. J Autoimmun. 2004; 23(3):233-9. DOI: 10.1016/j.jaut.2004.06.004. View

13.

Bouillon R, Verstuyf A, Verlinden L, Eelen G, Mathieu C . Prospects for vitamin D receptor modulators as candidate drugs for cancer and (auto)immune diseases. Recent Results Cancer Res. 2003; 164:353-6. DOI: 10.1007/978-3-642-55580-0_25. View

14.

van Etten E, Decallonne B, Bouillon R, Mathieu C . NOD bone marrow-derived dendritic cells are modulated by analogs of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol. 2004; 89-90(1-5):457-9. DOI: 10.1016/j.jsbmb.2004.03.017. View

15.

Reichel H, Koeffler H, Tobler A, Norman A . 1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A. 1987; 84(10):3385-9. PMC: 304875. DOI: 10.1073/pnas.84.10.3385. View

16.

Borissova A, Tankova T, Kirilov G, Dakovska L, Kovacheva R . The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract. 2003; 57(4):258-61. View

17.

Orwoll E, Riddle M, Prince M . Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr. 1994; 59(5):1083-7. DOI: 10.1093/ajcn/59.5.1083. View

18.

Overbergh L, Decallonne B, Valckx D, Verstuyf A, Depovere J, Laureys J . Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol. 2000; 120(1):139-46. PMC: 1905630. DOI: 10.1046/j.1365-2249.2000.01204.x. View

19.

Gysemans C, van Etten E, Overbergh L, Verstuyf A, Waer M, Bouillon R . Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3. Clin Exp Immunol. 2002; 128(2):213-20. PMC: 1906392. DOI: 10.1046/j.1365-2249.2002.01825.x. View

20.

Gysemans C, Cardozo A, Callewaert H, Giulietti A, Hulshagen L, Bouillon R . 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrinology. 2005; 146(4):1956-64. DOI: 10.1210/en.2004-1322. View